Skip to content

Effect of Guduchi Sheetkashay and Dhanyak Sheetkashay in the management of Garbhini Chardi

A comparative clinical study of Guduchi Sheetkashay and Dhanyak Sheetkashay in the management of Garbhini Chardi in first trimester - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096290
Enrollment
60
Registered
2025-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O219- Vomiting of pregnancy, unspecified

Interventions

None listed

Sponsors

Dr Neha Subhash Rathod
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All pregnant woman with Chardi in first trimester of pregnancy 2. Patients with pregnancy between 18-35 years of age 3. Patients willing for drug administration 4. Pregnant ladies with 3-4 episodes of vomiting

Exclusion criteria

Exclusion criteria: 1. Patients with hyperemesis gravidarum ( more than 4 episodes of vomiting ) 2. Patients in whom Chardi is seen in second and third trimester of pregnancy 3. Pregnant women with vomiting due to other systemic diseases such as intestinal obstruction, appendicitis, etc 4. Pregnant women with known case of diabetes mellitus 5. patients with multiple pregnancy 6. Patients with complications like severe dehydration 7. A known case of HIV, tuberculosis

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Guduchi Sheetkashay and Dhanyak Sheetkashay in the management of Garbhini Chardi in first trimesterTimepoint: Total duration of medication will be 15 days

Secondary

MeasureTime frame
NILTimepoint: NOT APPLICABLE

Countries

India

Contacts

Public ContactDr Neha Subhash Rathod

Ashvin Rural Ayurved College, Manchi Hill, Ashvi Bk, Sangamner. Dist. Ahmadnagar

vidya.sarode18@gmail.com8975019105

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026